financetom
Business
financetom
/
Business
/
Semler Scientific Prices $85 Million Private Offering of Convertible Notes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Semler Scientific Prices $85 Million Private Offering of Convertible Notes
Jan 24, 2025 6:16 AM

08:52 AM EST, 01/24/2025 (MT Newswires) -- Semler Scientific ( SMLR ) said Friday it has priced its $85 million private offering of 4.25% convertible senior notes due 2030, up from the initially planned $75 million.

The initial conversion rate of the notes will be 13.0826 shares per $1,000 principal amount of the notes, equivalent to an initial conversion price of about $76.44 per share.

In connection with the pricing, the company also entered into capped call transactions with certain financial institutions. The cap price of the capped call transactions will initially be about $107.01.

Net proceeds are estimated to be about $81.4 million or $95.8 million if the initial purchasers fully exercise their overallotment option. About $6.6 million of these proceeds will be allocated to the capped call transactions, with the remainder to be used for general corporate purposes, bitcoin acquisition, investments and strategic initiatives, among others, the company said.

The offering is set to close on Jan. 28.

Shares of the company fell 10% in recent premarket trading activity Friday.

Price: 54.99, Change: -6.16, Percent Change: -10.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NXP Semiconductors Not 'Immune' to Automotive Headwinds as Challenges Persist, Morgan Stanley Says
NXP Semiconductors Not 'Immune' to Automotive Headwinds as Challenges Persist, Morgan Stanley Says
Nov 9, 2024
11:13 AM EST, 11/06/2024 (MT Newswires) -- NXP Semiconductors ( NXPI ) is not immune to automotive headwinds as it is facing challenges throughout automotive and industrial and internet of things, Morgan Stanley said in a Tuesday note. The semiconductor manufacturer is preparing to end market weakness by reducing utilization and foundry purchases, expecting utilization will be in the low...
Why Sunrun (RUN) Stock Is Getting Hammered
Why Sunrun (RUN) Stock Is Getting Hammered
Nov 9, 2024
Sunrun Inc ( RUN ) shares are trading lower by 28% to $12.18 during Wednesday’s session in early trading on Wednesday following the election of Donald Trump as the 47th U.S. president. Trump’s victory, along with the Republican Party's renewed control of the Senate and lead in the House, signals a likely reversal of green energy policies that have directly...
Cerence Reports Kawasaki Picks Firm to Transform Rider Experience
Cerence Reports Kawasaki Picks Firm to Transform Rider Experience
Nov 9, 2024
11:09 AM EST, 11/06/2024 (MT Newswires) -- Cerence ( CRNC ) said Wednesday that Kawasaki has selected the company to transform rider experience across its motorcycle lineup. The company said Kawasaki will integrate its Cerence Ride platform, enabling access to navigation, vehicle controls and cloud applications through a voice-powered AI assistant. Cerence Ride is compatible with both Android and iOS...
Plus Therapeutics, SpectronRx Collaborate to Manufacture Rhenium Obisbemeda Radiotherapy
Plus Therapeutics, SpectronRx Collaborate to Manufacture Rhenium Obisbemeda Radiotherapy
Nov 9, 2024
10:46 AM EST, 11/06/2024 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Wednesday it has signed a manufacturing services agreement with SpectronRx to produce Rhenium Obisbemeda, a radiotherapy for central nervous system cancers. Financial details weren't disclosed. Under the agreement SpectronRx will use its facilities to produce late-stage clinical and commercial supplies of Rhenium Obisbemeda, the company said. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved